AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This study is a non-inferiority phase III randomized trial evaluating the effect of
intranasal midazolam versus intramuscular loxapine on the rapid tranquilization of agitated
patient in emergency department. Intranasal midazolam is safe and may allow a management of
extreme agitation state and prevent adverse effects.